Medications for Chronic Lymphocytic Leukemia

12 results

  • bendeka - bendamustine hydrochloride injection, solution

    (Bendamustine Hydrochloride)
    Teva Pharmaceuticals Usa, Inc.
    BENDEKA treats chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
    Medication Details
    Drug Interactions

  • breyanzi

    (Lisocabtagene Maraleucel)
    Juno Therapeutics, Inc.
    Breyanzi is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle cell lymphoma, or marginal zone lymphoma after 2 or more prior lines of therapy. Not indicated for primary CNS lymphoma.
    Medication Details

  • brukinsa - zanubrutinib capsule

    (Zanubrutinib)
    Beone Medicines Usa, Inc.
    BRUKINSA is a kinase inhibitor for adults with mantle cell lymphoma, Waldenström's macroglobulinemia, chronic lymphocytic leukemia or small lymphocytic lymphoma, relapsed/refractory marginal zone lymphoma, and relapsed/refractory follicular lymphoma (with obinutuzumab).
    Medication Details
    Drug Interactions

  • calquence - acalabrutinib tablet, film coated

    (Acalabrutinib)
    Astrazeneca Pharmaceuticals Lp
    CALQUENCE treats adults with mantle cell lymphoma (MCL) — either previously untreated (with bendamustine and rituximab, when ineligible for stem cell transplant) or after prior therapy — and adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
    Medication Details
    Drug Interactions

  • copiktra - duvelisib capsule

    (Duvelisib)
    Secura Bio, Inc
    Copiktra treats adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior systemic therapies. Not indicated as initial or second-line treatment due to increased risk of treatment-related mortality.
    Medication Details
    Drug Interactions

  • gazyva - obinutuzumab injection, solution, concentrate

    (Obinutuzumab)
    Genentech, Inc.
    GAZYVA treats previously untreated chronic lymphocytic leukemia (with chlorambucil), relapsed or refractory follicular lymphoma after rituximab-containing regimens (with bendamustine), previously untreated stage II bulky, III, or IV follicular lymphoma (with chemotherapy), and active lupus nephritis in adults on standard therapy.
    Medication Details
    Drug Interactions

  • jaypirca - pirtobrutinib tablet, coated

    (Pirtobrutinib)
    Eli Lilly And Company
    Jaypirca treats adults with relapsed or refractory mantle cell lymphoma (MCL) after two or more prior therapies including a BTK inhibitor, and adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) after a covalent BTK inhibitor.
    Medication Details
    Drug Interactions

  • rituxan - rituximab injection, solution

    (Rituximab)
    Genentech, Inc.
    Rituxan treats Non-Hodgkin's Lymphoma (adults and pediatric patients 6+ months), Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis unresponsive to TNF antagonists, Granulomatosis with Polyangiitis and Microscopic Polyangiitis (ages 2+), and moderate-to-severe Pemphigus Vulgaris in adults.
    Medication Details
    Drug Interactions

  • rituxan hycela - rituximab and hyaluronidase injection, solution

    (Rituximab And Hyaluronidase)
    Genentech, Inc.
    Rituxan Hycela treats adult patients with follicular lymphoma (relapsed/refractory, previously untreated, or non-progressing after CVP), previously untreated diffuse large B-cell lymphoma with chemotherapy, and previously untreated or treated chronic lymphocytic leukemia with fludarabine and cyclophosphamide. Requires prior IV rituximab dose.
    Medication Details
    Drug Interactions

  • ruxience - rituximab - pvvr injection, solution

    (Rituximab-Pvvr)
    Pfizer Laboratories Div Pfizer Inc
    Ruxience treats adult patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis (after TNF antagonist failure), Granulomatosis with Polyangiitis, Microscopic Polyangiitis, and moderate-to-severe Pemphigus Vulgaris.
    Medication Details
    Savings Programs
    1
    Drug Interactions